{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/002/SRR5927362/SRR5927362.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/004/SRR5927364/SRR5927364.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/009/SRR5927359/SRR5927359.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/001/SRR5927361/SRR5927361.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/007/SRR5927357/SRR5927357.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/006/SRR5927366/SRR5927366.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/005/SRR5927365/SRR5927365.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/008/SRR5927358/SRR5927358.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/008/SRR5927368/SRR5927368.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/000/SRR5927360/SRR5927360.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/007/SRR5927367/SRR5927367.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR592/003/SRR5927363/SRR5927363.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["GENE REGULATION, RESEARCH, PETER MACCALLUM CANCER CENTRE"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA397984"],"scientific_name":["Homo sapiens"],"long_description":["Gene expression profiling was performed to characterise transcriptional programs associated with response to type I JAK2 inhibitor ruxolitinib, type II JAK2 inhibitor CHZ868 or shRNA-mediated JAK2 knockdown in MHH-CALL4 cells. Overall design: CRLF2-rearranged/JAK2I682F-expressing MHH-CALL4 cells were treated with vehicle (DMSO), CHZ868 (300 nM) or ruxolitinib (1000 nM) for 24 hours in duplicate and total RNA was freshly extracted for 3'-RNA-Seq. MHH-CALL4 cells were transduced with constitutive (pLMS-GFP) retroviral vectors harbouring shRNAs targeting JAK2 (shJAK2.209 or shJAK2.2826) or scrambled (shSCR) in duplicate and GFP+ cells were harvested at day 5 post-transduction for 3'-RNA-Seq."],"tag":["xref:PubMed:29907650"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Homo sapiens","description":"Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro","dates":{"last_updated":"2025-09-24","first_public":"2018-01-02"},"accession":"PRJNA397984","cross_references":{"GEO":["GSE102534"],"taxon":["9606"],"PubMed":["29907650"]}}